| Dr Christopher Mcculloh, MD | |
|
1540 E Hospital Dr, Ann Arbor, MI 48109-4000 | |
| (734) 764-4151 | |
| Not Available |
| Full Name | Dr Christopher Mcculloh |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 1540 E Hospital Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477994234 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 25MA10486200 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Mcculloh, MD 1540 E Hospital Dr, Ann Arbor, MI 48109-4000 Ph: () - | Dr Christopher Mcculloh, MD 1540 E Hospital Dr, Ann Arbor, MI 48109-4000 Ph: (734) 764-4151 |
News Archive
A latest study reveals that the risk for stroke maybe tied to blood type, with men and women with type AB and women with type B facing greater risk than people with type O. Researchers add that this study does not prove the link but it agrees with other studies that have tied A, B, and AB to heart attack and to blood clots in the legs. And type O has been linked to a heightened risk for bleeding, which implies less chance of the clots that are responsible for most strokes.
Affymetrix, Inc. today announced commercialization of the next-generation human transcriptome array demonstrated by Stanford University researchers to be superior to mRNA sequencing (RNA-Seq) in gene expression profiling studies.
In what is believed to be the largest dataset study to date examining the role of race on survival outcome for pediatric patients with Hodgkin lymphoma, investigators at Rutgers Cancer Institute of New Jersey have found that black patients have significantly worse overall survival at five years than white patients when accounting for all available clinical variables.
Harvest Technologies Corp. (www.harvesttech.com) announced today that the Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to commence its BMAC Enhanced CABG Trial. This is a two phase 42-patient 'feasibility' clinical trial using the company's BMAC System to concentrate autologous bone marrow cells to treat patients with congestive heart failure undergoing treatment with coronary artery bypass grafting (CABG) Surgery.
› Verified 1 days ago
John C Magee, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Steven W Bruch, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr., 4th Floor, C.s. Mott Children's Hospital, Ann Arbor, MI 48109 Phone: 734-764-4151 | |
Theodore Hobart Welling, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, 2nd Floor Taubman Ctr Recp F, Ann Arbor, MI 48109 Phone: 734-936-5738 | |
Eiichi A Miyasaka, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Department Of Surgery, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Nathan Louras, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Robert J Beaulieu, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Meredith Barrett, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |